Nilandron is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Nilutamide.
| Product ID | 59212-111_1c7bf50a-82ee-49ac-b1bc-35d1a2e60f36 | 
| NDC | 59212-111 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Nilandron | 
| Generic Name | Nilutamide | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2013-07-15 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020169 | 
| Labeler Name | Concordia Pharmaceuticals Inc. | 
| Substance Name | NILUTAMIDE | 
| Active Ingredient Strength | 150 mg/1 | 
| Pharm Classes | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2013-07-15 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020169 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2016-01-01 | 
| Marketing End Date | 2018-10-25 | 
| Marketing Category | NDA | 
| Application Number | NDA020169 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2013-07-15 | 
| Ingredient | Strength | 
|---|---|
| NILUTAMIDE | 150 mg/1 | 
| SPL SET ID: | 5ccf0e9a-8935-4c8c-b883-b4967281eb4a | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 59212-111 | Nilandron | Nilutamide | 
| 82454-0111 | Nilandron | Nilutamide | 
| 62559-173 | Nilutamide | Nilutamide | 
| 66993-212 | Nilutamide | Nilutamide | 
| 82454-0212 | Nilutamide | Nilutamide | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  NILANDRON  74646174  1949186 Live/Registered | CONCORDIA PHARMACEUTICALS INC. 1995-03-13 |